Liebe Besucherinnen und Besucher,
aufgrund unseres Sommerfestes sind wir am 03. September 2026 bis 14 Uhr erreichbar. Am 04. September 2026 sind wir wieder wie gewohnt für Sie da. Vielen Dank für Ihr Verständnis.
Ihr Team von Sack Fachmedien
Buch, Englisch, 392 Seiten, Format (B × H): 178 mm x 254 mm, Gewicht: 1049 g
Reihe: Contemporary Endocrinology
Buch, Englisch, 392 Seiten, Format (B × H): 178 mm x 254 mm, Gewicht: 1049 g
Reihe: Contemporary Endocrinology
ISBN: 978-0-89603-591-1
Verlag: Springer Nature B.V.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
I Hormonal Control of Mammary Development and Growth.- 1 Hormonal Control of Normal Breast Morphology and Function.- 2 Interactions Between Estradiol and Progesterone in Normal Breast: Implications for Mammary Carcinogenesis.- 3 Expression and Regulation of Insulin-like Growth Factors and Their Binding Proteins in the Normal Breast.- II Carcinogenesis.- 4 Estrogens and Breast Cancer: An Epidemiologic Perspective.- 5 Androgens, Estrogens, and Breast Cancer Risk.- 6 Local Estrogen Production: Is Aromatase An Oncogene?.- 7 Oncogenes and Mammary Carcinogenesis.- 8 Categorization of Breast Cyst Fluid and Breast Cancer Risk.- III Tumor Progression.- 9 The Role of Tumor Suppressor Genes in Breast Cancer Progression.- 10 Oncogene Activation and Breast Cancer Progression.- 11 Interactions Between Stroma and Epithelium in Breast Cancer: Implications for Tumor Genesis, Growth, and Progression.- 12 The Role of Angiogenesis in the Transition to Hormone Independence and Acquisition of the Metastatic Phenotype.- 13 Role of the IGF System in Breast Cancer Proliferation and Progression.- 14 Prognostic and Predictive Factors in Breast Cancer.- 15 Role of the Polyamine Pathway in the Natural History of Breast Cancer.- IV Estrogen, Progestins, and Prolactin in Breast Cancer Biology: Targets for Treatment.- 16 Aromatase Inhibitors in Breast Carcinoma.- 17 Role of Progestins and Progesterone Receptors in Breast Cancer Biology.- 18 Prolactin and its Receptors in Human Breast Cancer.- V Endocrine Therapy of Breast Cancer.- 19 Pharmacology and Use of Antiestrogens in Treatment and Chemoprevention of Breast Cancer.- 20 LHRH Superagonists and Antagonists in the Treatment of Breast Cancer.- VI Benign Breast Disease.- 21 Benign Breast Lesions: Pathologic Classification and Risk Potential.- 22 Hormonal Treatment of Fibrocystic Disease.- 23 Gynecomastia and Galactorrhea.




